BCMA Targeted Therapies Summit

Paid

There aren’t many targets like BCMA - well validated, preferentially expressed by mature B lymphocytes and specific to multiple myeloma – meaning that novel drugs against BCMA continue to emerge.

12-14 July 2022

Healthcare

5th Annual Cell Engager Summit

Paid

Welcome to the 5th Annual Cell Engager Summit! Tecytinib’s approval last year has strongly fuelled the mentality that this is the year of cell engager! Bispecifics have led the way and liquid tumors have been hit hard. Now Immunocore and others are starting to take the fight to solid tumors. The 5th Annual Cell Engager Summit returns this year de

25-27 April 2023

Healthcare

Advances in CAR T Therapy

Paid

Cell therapies such as CAR Ts are now a proven treatment approach for hematological cancers, but challenges remain around CAR T’s ability to target solid tumors. Cambridge Healthtech Institute’s Tenth Annual Advances in CAR T Therapy conference brings together leading researchers and companies to discuss the latest developments in CAR T and CAR-ena

07-08 August 2023

Healthcare